ECCO 15- ESMO 34, Berlin 2009: European Association for Cancer Research

ECCO 15 ESMO 34, Berlin, 2009: The human papilloma virus and cervical cancerПодробнее

ECCO 15 ESMO 34, Berlin, 2009: The human papilloma virus and cervical cancer

ECCO 15 ESMO 34, Berlin, 2009: Targeted heat therapy for soft tissue sarcomaПодробнее

ECCO 15 ESMO 34, Berlin, 2009: Targeted heat therapy for soft tissue sarcoma

ECCO 15 ESMO 34, Berlin, 2009: New cancer research priorities.Подробнее

ECCO 15 ESMO 34, Berlin, 2009: New cancer research priorities.

ECCO 15 ESMO 34 Berlin 2009: Surgery improves survival in metastatic breast cancer patientsПодробнее

ECCO 15 ESMO 34 Berlin 2009: Surgery improves survival in metastatic breast cancer patients

ECCO 15 ESMO 34 Berlin 2009: Medical cancer therapy beyond standard chemotherapyПодробнее

ECCO 15 ESMO 34 Berlin 2009: Medical cancer therapy beyond standard chemotherapy

ECCO 15 ESMO 34 Berlin 2009: Advanced radiotherapyПодробнее

ECCO 15 ESMO 34 Berlin 2009: Advanced radiotherapy

ECCO 15 ESMO 34 Berlin 2009: Translational research - a contribution to future cancer treatmentПодробнее

ECCO 15 ESMO 34 Berlin 2009: Translational research - a contribution to future cancer treatment

ECCO 15 ESMO 34, Berlin, 2009: Prostate cancer, hormone therapy and heart disease.Подробнее

ECCO 15 ESMO 34, Berlin, 2009: Prostate cancer, hormone therapy and heart disease.

ECCO 15 ESMO 34, Berlin, 2009: Two treatments for advanced melanoma increase survivalПодробнее

ECCO 15 ESMO 34, Berlin, 2009: Two treatments for advanced melanoma increase survival

ECCO 15 ESMO 34, Berlin, 2009: New European Academy of Cancer Sciences.Подробнее

ECCO 15 ESMO 34, Berlin, 2009: New European Academy of Cancer Sciences.

ECCO 15- ESMO 34, Berlin 2009: Circulating tumour cellsПодробнее

ECCO 15- ESMO 34, Berlin 2009: Circulating tumour cells

ECCO 15- ESMO 34, Berlin 2009: Prioritisation in cancer researchПодробнее

ECCO 15- ESMO 34, Berlin 2009: Prioritisation in cancer research

ECCO 15- ESMO 34, Berlin 2009: Guidelines for safer handling of cytotoxicsПодробнее

ECCO 15- ESMO 34, Berlin 2009: Guidelines for safer handling of cytotoxics

ECCO 15- ESMO 34, Berlin 2009: Current situation with aromatase inhibitorsПодробнее

ECCO 15- ESMO 34, Berlin 2009: Current situation with aromatase inhibitors

ECCO 15 ESMO 34 Berlin 2009: Cancer survivorship for the patient's quality of lifeПодробнее

ECCO 15 ESMO 34 Berlin 2009: Cancer survivorship for the patient's quality of life

ECCO 15- ESMO 34, Berlin 2009: The problems of getting new molecules to the clinicПодробнее

ECCO 15- ESMO 34, Berlin 2009: The problems of getting new molecules to the clinic

ECCO 15- ESMO 34, Berlin 2009: PET in the treatment of Hodgkin's LymphomaПодробнее

ECCO 15- ESMO 34, Berlin 2009: PET in the treatment of Hodgkin's Lymphoma

ECCO 15- ESMO 34, Berlin 2009: Costs of licensing clinical trialsПодробнее

ECCO 15- ESMO 34, Berlin 2009: Costs of licensing clinical trials

ECCO 15- ESMO 34, Berlin 2009: Early detection of cancerПодробнее

ECCO 15- ESMO 34, Berlin 2009: Early detection of cancer

ECCO 15- ESMO 34, Berlin 2009: Triple negative breast cancerПодробнее

ECCO 15- ESMO 34, Berlin 2009: Triple negative breast cancer